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Abstract 
Autophagy (literally “self-eating”) is an evolutionarily conserved degradation process where 
cytoplasmic components are engulfed by vesicles called autophagosomes, which are then 
delivered to lysosomes, where their contents are degraded. Under stress conditions, such as 
starvation or oxidative stress, autophagy is upregulated in order to degrade macromolecules 
and restore the nutrient balance. The source of membranes that participate in the initial 
formation of phagophores is still incompletely understood and many intracellular structures 
have been shown to act as lipid donors, including the endoplasmic reticulum, Golgi, nucleus, 
mitochondria and the plasma membrane. Here we focus on the contributions of the plasma 
membrane to autophagosome biogenesis governed by ATG16L1 and ATG9A trafficking, and 
summarise the physiological and pathological implications of this macroautophagy route, from 
development and stem cell fate to neurodegeneration and cancer. 
 
 
 
Introduction to autophagy 
Macroautophagy (henceforth autophagy) is an evolutionary conserved intracellular pathway that 
enables the degradation of proteins, lipids, macromolecular complexes including oligomeric proteins, 
organelles including mitochondria, and various intracellular pathogens [1]. These substrates are 
sequestered by double-layered, cup-shaped structures called phagophores, which form 
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autophagosomes after their edges extend and join [2]. The completed autophagosomes then traffic 
along microtubules towards the microtubule-organising centre of the cell where lysosomes are 
clustered [3]. This brings the autophagosomes into proximity with lysosomes and facilitates their 
fusion, after which the lysosomal hydrolases can degrade the autolysosomal contents [4].  
A key unresolved question in the field is how the double-membraned autophagosomes are sculpted. 
Various membrane sources have been implicated in the formation of autophagosomes, including the 
endoplasmic reticulum (ER) [5-7], mitochondria [8], ER-mitochondrial contact sites [9], the Golgi 
[10], ER exit sites [11, 12] and the plasma membrane  [13-15]. Here we will consider how the plasma 
membrane is involved in autophagy and how autophagy may regulate various signals from the plasma 
membrane. These discussions do not obviate roles for other membrane sources – indeed, it is our 
belief that autophagosomes derive their membranes from multiple cellular compartments. 
Autophagosome formation is regulated and enabled by many proteins, many of which are known as 
ATG proteins. Among these 30 or so proteins, a key player is LC3, one of 6 members of the Atg8 
family [16]. LC3, like its family members, is translated in a precursor form and becomes LC3-I after 
its C-terminal is cleaved to expose a glycine residue [17, 18]. It then becomes an ubiquitin-like 
molecule that can be  conjugated via its glycine to the lipid phosphatidylethanolamine (as opposed to 
a protein) in a reaction enabled by the E1-like enzyme, ATG7 and the E2-like enzyme ATG3 [19]. 
This conjugation is facilitated by the E3-like activity of the ATG5-12-ATG16L1 complex [20]. This 
latter complex is formed after the ubiquitin-like conjugation of ATG12 to ATG5 and the complexing 
of this conjugate with ATG16L1, which is thought to dictate the sites of LC3-lipidation (and hence 
autophagosome formation). The LC3 lipidation event appears to enable the expansion and closure of 
the autophagosome membranes. ATG16L1-LC3 double-positive structures are considered to be 
phagophores, while the ATG16L1 complex is removed from closed autophagosomes, which are 
ATG16L1-negative and LC3-positive [21]. The final closure stages may involve steps akin to scission 
(as occurs in endocytosis or multivesicular body formation), rather than simple fusion events   [22]. 
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In this short review, we will consider how trafficking events from the plasma membrane may regulate 
autophagosome formation, as well as how autophagy can regulate aspects of biology at the plasma 
membrane. We will not consider processes like LC3-associated phagocytosis which use some 
components of the autophagy machinery but are not strictly autophagy. 
 
ATG16L1 traffics from the plasma membrane to sites of autophagosome biogenesis 
ATG16L1 is a cytosolic protein which associates with clathrin-coated pits on the plasma membrane 
via its interaction with clathrin adaptor protein AP2. If one labels the plasma membrane with various 
different lipid-binding dyes, these associate first with ATG16L1 and then with LC3-positive 
autophagosomes, suggesting that the plasma membrane-associated ATG16L1 traffics to sites of 
autophagosome biogenesis [13]. If clathrin-dependent endocytosis is inhibited, then autophagosome 
biogenesis is reduced, and if endosomal scission is inhibited, then ATG16L1 accumulates in the 
scission intermediates. Subsequent studies suggest that ATG16L1 can also be trafficked from the 
plasma membrane via clathrin-independent forms of endocytosis [23]. 
After endocytosis, the ATG16L1-positive structures undergo SNARE-dependent homotypic fusion 
events which increase the size of the resultant vesicles and enhance their ability to acquire LC3. Thus, 
these homotypic fusion events (which may be complex involving more than one set of SNAREs), 
enable the conversion of ATG16L1-positive, LC3-negative phagophore precursors into phagophores. 
Indeed, the EM morphology of some of the fusion products are compatible with what one may expect 
from early phagophores [15]. 
 
ATG9A meets ATG16L1 in recycling endosomes 
ATG9A is a multipass transmembrane protein that is important for autophagosome biogenesis. Its 
exact roles are poorly understood, but it may assist in bringing membrane to forming phagophores 
thereby helping them to grow. While LC3-II-positive structures do not form in ATG16-null cells, the 
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formation of such structures as well as ATG16L1 vesicles is reduced but not ablated in ATG9A-
knockdown cells, and ATG9A appears to associate with autophagosome precursors early in their 
biogenesis [24]. ATG9A is also associated with clathrin-coated pits at the plasma membrane [14, 25], 
but is seen in distinct pits from ATG16L1. ATG9A traffics through a conventional route via early 
endosomes to recycling endosomes where the ATG9A-containing vesicles fuse with the AT16L1-
containing vesicles in a process regulated by distinct SNAREs from the homotypic fusions of the 
ATG16L1 vesicles. This fusion event, regulated by VAMP3, is also critical for autophagosome 
biogenesis. The ATG16L1 vesicles traffic to recycling endosomes bypassing early endosomes, hence 
different vesicles which contribute to autophagosome biogenesis traffic from different sites on the 
plasma membrane via different paths to the recycling endosomes where they meet [14] – see Figure 1. 
At present it is not clear whether the so-called homotypic ATG16L1—ATG16L1 vesicle fusion 
events occur before or after the heterotypic ATG16L1-ATG9A fusion events, or whether there is a 
dependency on the one type of fusion for the other.  
Additional regulation of recycling endosome-associated ATG16L1 is mediated by the PX-BAR 
protein SNX18. After autophagy induction, Atg16L1-positive recycling endosomes redistribute in a 
Rab11- and SNX18-dependent manner to a perinuclear SNX18-positive region where Atg16L1 
enables LC3, recruitment followed by SNX18-mediated membrane remodeling that provides 
membranes for autophagosome biogenesis [26]. 
The itinerary of ATG9A may be complex and it appears that ATG9A needs to be maintained in a 
cycling pool which involves recycling endosomes and the early Golgi, and possibly other 
compartments. TBC1D14, a negative regulator of autophagy that controls delivery of membranes 
from RAB11-positive recycling endosomes to forming autophagosomes binds to the TRAPP 
complex. A model has been proposed the maintenance of this cycling pool, which is required for 
autophagy, is maintained by the trafficking mediated by TBC1D14 via its interaction TRAPPIII [27]. 
Interestingly, similar Atg9 trafficking events are regulated by TRAPIII in yeast [28]. 
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Physiological regulation 
When cells are exposed to starvation, a primordial autophagy stimulus, there is increased mobility of 
vesicles emanating from the plasma membrane and increased homotypic and heterotypic fusions [14, 
15]. This could be accounted for by the transcriptional upregulation of the actin-remodelling protein 
Annexin A2 after starvation in tissue culture and in vivo. Annexin A2 transcription is positively 
regulated by starvation via activation of JNK leading to increased binding of c-Jun to its promoter 
[29]. Annexin A2 knockdown impairs basal and starvation-induced autophagy, and its overexpression 
enhances autophagy – hence it is necessary and sufficient for starvation-induction of autophagy [29, 
30]. This may be because this protein positively regulates both the endocytosis and homotypic fusion 
of the ATG16L1-containing vesicles [30], as well as the actin-dependent trafficking of the ATG9A-
containing vesicles from early to recycling endosomes and thus heterotypic fusion  [15].  
 
Diseases where ATG16L1 and ATG9A trafficking are perturbed. 
These trafficking events appear to be perturbed by disease-associated genetic variants. The D620N 
mutation in VPS35 causes a rare autosomal dominant form of Parkinson’s disease [31, 32]. This 
mutation impairs autophagy and leads to the accumulation of alpha-synuclein, an autophagy substrate 
whose accumulation is pathognomonic for Parkinson’s disease. D620N VPS35 associates poorly with 
the actin-remodelling WASH complex and cells expressing this mutant have impaired WASH 
association with endosomes. This affects the acting-dependent trafficking of the ATG9A-containing 
endosomes and reduces heterotypic fusion events [33]. 
The CALM (also known as PICALM) gene is within a well validated locus which has been associated 
with increased risk for Alzheimer’s disease in genome-wide association studies [34, 35]. While the 
causative variant has not been established, there are suggestions that CALM expression is reduced in 
Alzheimer’s disease brains [36-38]. CALM regulates the endocytosis of various SNAREs from the 
plasma membrane and these defects impact various stages of autophagy. Autophagosome biogenesis 
is compromised because of defective endocytosis of VAMP2, which affects homotypic fusion, as well 
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as VAMP3, which regulates the heterotypic fusion. Autophagosome-degradation is impaired because 
of reduced endocytosis of VAMP8, which regulates autophagosome-lysosome fusion. This results in 
the accumulation of tau, an autophagy substrate which accumulates in Alzheimer’s disease, where it is 
thought to be an important driver of pathology [39].   
 
Neurodevelopment and stem cell fate 
Recently, the degradation of Notch1 from the plasma membrane has been shown to be regulated by 
autophagy, in addition to its conventional endocytic route [40]. Enhanced autophagy increases Notch1 
degradation and reduces its downstream signalling, while impairing autophagy via a range of genetic 
perturbations had the converse effects in cell culture and in vivo. Notch1 is endocytosed with 
ATG16L1 from the ATG16L1-containing coated pits where the vesicles containing both proteins 
traffic to recycling endosomes to meet ATG9A-containing vesicles in a VAMP3-dependent fashion. 
Thus, this plasma membrane protein is directly incorporated into autophagic precursor structures prior 
to the phagophore stage, and then enters the autophagosomes for degradation.   Notch1 is an 
important regulator of stem cell fate and impaired conversion of stem cells to more differentiated 
types were seen in a range of tissues from an AT16L1 autophagy hypomorphic mouse model. For 
example, there was impaired neurogenesis from embryonic and adult neuronal stem cells in this 
model – this may contribute to pathology in diseases where there is modest autophagy compromise 
[40].  
 
Focal adhesion and tight junction turnover 
The degradation of components associated with the plasma membrane may also be mediated via 
autophagy receptors, which serve as a link between the relevant substrate protein and the components 
of the autophagosome, like LC3. Such a mechanism is important for the degradation of cell-matrix 
focal adhesions (FAs) when they are disassembled at the basal cell membrane.  This process is 
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thought to be largely mediated by the autophagy cargo receptor, neighbour of BRCA1 (NBR1) [41]. 
Recent studies have additionally shown that upon autophagy-induced Src activation, the disassembly 
and turnover of FAs depend on the direct interaction between the conserved LIR motif in the amino-
terminal end of paxillin (an early precursor and important constituent of FAs) and LC3 [42]. These 
data may explain why autophagy is required for cell migration, invasion and metastasis, at least in the 
4T1 orthotopic mouse mammary tumor model, in which 4T1 murine mammary carcinoma cells 
implanted into the mammary fat pad of syngeneic Balb/C mice [42]. 
As part of the lateral plasma membrane, adherens junctions (AJ) and tight junctions (TJ) function in 
controlling cell-cell adhesion and paracellular barrier functions, both required for maintaining cell 
polarity, a phenomenon lost upon epithelial mesenchymal transition (EMT) and tumor invasiveness 
[43]. Indeed, autophagy increases E-cadherin degradation (a major transmembrane component of AJ) 
and thus facilitates AJ dissolution during EMT [44]. Furthermore E-cadherin levels may be 
transcriptionally repressed in autophagy-deficient cells, where increased levels of p62 stabilise the 
oncogenic transcription factor Twist1, which supresses E-cadherin synthesis and potentiates EMT 
[45]. However, the molecular events involved in the process of autophagy-dependent AJ disassembly 
are not completely understood and likely involve other processes. For example, degradation of the TJ 
protein claudin-2 by autophagy leads to reduced epithelial TJ permeability with increased paracellular 
barrier properties, a phenomenon relevant to inflammatory bowel disease [46]. 
 
 
 
Connexins and autophagy - a case of mutual regulation. 
Connexins are another group of lateral plasma membrane proteins which are degraded via autophagy. 
At present, it is not clear if they are directly incorporated into autophagic precursor structures like 
Notch1, or degraded via an autophagy receptor-like mechanism, like focal adhesions. However, what 
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is striking is that there is a reciprocal regulation of autophagy by connexins [47]. Connexins localised 
to the plasma membrane inhibit autophagy by interacting with various proteins that regulate 
autophagosome biogenesis, like ATG16L1, VPS34, Beclin-1 and VPS15. When autophagy is induced 
by starvation, this effect is reversed by the arrival of ATG14 to this ATG-Connexin complex, which 
enables its internalization along with ATG9A. The resulting autophagic degradation of the connexions 
reduces the levels of these inhibitory proteins, thereby enabling more long-lasting autophagy 
activation [47].  
 
Ciliogenesis-autophagy interplay 
Another mechanism of mutual regulation links autophagy to ciliogenesis. Starvation induces 
autophagy by relocalizing certain autophagy proteins (ATG16L1, AMBRA1, LC3, GABARAPL1) to 
cilia and thus promoting the increased cilia-plasma membrane turnover required for effective 
ciliogenesis. Ciliogenesis also upregulates autophagy, potentially enabling  a self-sustaining 
feedforward mechanism: ciliogenesis-autophagy-ciliogenesis [48]. Recent studies have shown that 
mechanical stimuli such as fluid flow trigger and perpetuate this feedforward loop, as autophagy plays 
a central role in reducing cell size/shape that further accentuates ciliogenesis  [49]. In this way, 
autophagy may respond to fluid flow in the kidney to regulate epithelial cell size [49].  
 
Conclusions 
Recent studies suggest multiple layers of regulation between the plasma membrane and its associated 
proteins and autophagy (Figure 2). On the one hand, autophagy proteins traffic via the plasma 
membrane to sites of autophagosome biogenesis and factors regulating their endocytosis impact 
autophagy. Then, SNAREs which regulate key fusion steps in autophagy are regulated by 
endocytosis. Importantly, autophagy can also regulate cell fate by influencing the degradation of 
proteins that impact differentiation, like Notch1 or proteins that affect migration. 
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Finally, connexins provide an example of how an autophagy inhibitory machinery at the plasma 
membrane can itself be degraded by autophagy, thereby providing an autoregulatory positive 
feedback which can boost many aspects of autophagy.     
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Figure 1. Plasma membrane contribution to autophagosome biogenesis.  
The plasma membrane represents an important source of ATG9A and ATG16L1 vesicles [13-15]. 
ATG9A is internalized in clathrin coated pits and delivered to recycling endosomes (RE) through the 
conventional transferrin receptor internalization route via early endosomes (EE) [14, 25]. ATG16L1 
also interacts with AP2-clathrin structures at the plasma membrane [13]. However, the pool of 
clathrin coated vesicles containing ATG16L1 is distinct from that containing ATG9A, and do not 
follow the conventional internalization pathway, being directly delivered to recycling endosomes [14]. 
The heterotypic fusion of ATG9A- and ATG16L1-positive vesicles in the RE is mediated by VAMP3, 
which is attached to ATG9A-positive vesicles in early endosomes [14]. The homotypic fusion 
between ATG16L1 vesicles is mediated by different SNARE complexes, such as the plasma 
membrane-derived SNARE, VAMP7 [15]. Upon starvation, annexin A2 expression is induced by c-
JUN activation to facilitate both the ATG9A sorting from early endosomes to recycling endosomes 
[29] and the homotypic fusion of ATG16L1-positive vesicles through recruiting phosphatidylserine 
and phosphatidylinositides [30]. The phagophores evolve towards autophagosomes that ultimately 
fuse with lysosomes and form autolysosomes. 
 
Figure 2. Physiological relevance for plasma membrane contribution to autophagy. 
Upon autophagy induction, (1) Notch1 [40] and (2) cilium factors (GLI1/2) [48] traffic together with 
ATG16L1 to be delivered and degraded by autophagy. At the plasma membrane, (3) connexins 
require ATG9 to be delivered to autophagosomes for degradation [47]. Focal adhesion disassembly is 
mediated by autophagy by increased paxillin degradation through either (4a) direct paxillin-NBR1 
interaction [41] or (4b) direct paxillin-LC3 interaction upon Src activation [42]. Autophagy 
upregulation also degrades (5) tight junction proteins (claudin2) [46] and (6) adherens junctions 
proteins (E-cadherins) [44] through yet unclarified routes. Autophagy inhibition increases the levels 
of p62 which stabilize Twist1 in the nucleus to transcriptionally repress E-cadherin expression [45].  
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